Test of Cure for Anogenital Gonorrhoea Using Modern RNA-Based and DNA-Based Nucleic Acid Amplification Tests: A Prospective Cohort Study | Zendy

Carolien M. Wind | Zendy; Maarten F. Schim van der Loeff | Zendy; Magnus Unemo | Zendy; Rob Schuurman | Zendy; Alje P. van Dam | Zendy; Henry J.C. de Vries | Zendy

Open Access

Test of Cure for Anogenital Gonorrhoea Using Modern RNA-Based and DNA-Based Nucleic Acid Amplification Tests: A Prospective Cohort Study

Author(s) -

Carolien M. Wind,

Maarten F. Schim van der Loeff,

Magnus Unemo,

Rob Schuurman,

Alje P. van Dam,

Henry J.C. de Vries

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw141

Subject(s) - medicine , nucleic acid amplification tests , azithromycin , prospective cohort study , cohort , clearance , doxycycline , chlamydia , neisseria gonorrhoeae , rna , virology , chlamydia trachomatis , antibiotics , immunology , microbiology and biotechnology , biology , urology , biochemistry , gene

The use of nucleic acid amplification tests (NAATs) to diagnose Neisseria gonorrhoeae infections complicates the performance of a test of cure (TOC) to monitor treatment failure, if this is indicated. As evidence for the timing of TOC using modern NAATs is limited, we performed a prospective cohort study to assess time to clearance when using modern RNA- and DNA-based NAATs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research